Skip to main content
logo
Opus Genetics, Inc. (IRD)
NASDAQ: IRD · Real-Time Price · USD
3.350
+0.270 (8.77%)
At close: Jul 27, 2026, 4:00 PM EDT
3.358
+0.007 (0.22%)
After-hours: Jul 27, 2026, 6:06 PM EDT

Opus Genetics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
11.9814.210.9919.0539.850.59
Revenue Growth
-12.22%29.15%-42.30%-52.20%6665.70%-
Gross Profit
11.9814.210.9919.0539.850.59
Operating Income
-43.03-38.6-62.07-10.5618.23-22.71
Net Income
-106.93-49.59-57.53-9.9917.89-56.69
Earnings Per Share
-1.33-0.80-2.15-0.460.87-3.82
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
59.9645.0930.3250.5242.6824.75
Total Debt
000000.54
Net Cash (Debt)
59.9645.0930.3250.5242.6824.22
Net Cash Growth
43.47%48.70%-39.97%18.35%76.27%47.66%
Net Cash Per Share
0.800.721.142.342.071.63

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-38.99-35.25-25.58-1.1114.31-19.37
Free Cash Flow
-38.99-35.25-25.58-1.1114.31-19.37
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin
-359.13%-271.90%-564.72%-55.45%45.74%-3854.84%
Pretax Margin
-886.15%-349.33%-523.40%-52.36%45.68%-9625.30%
Profit Margin
-892.36%-349.33%-523.40%-52.42%44.89%-9625.30%
FCF Margin
-325.34%-248.33%-232.68%-5.84%35.92%-3288.62%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-6.026.026.0214.08-
PS Ratio
22.819.903.42---